BCYC - Company ID 0001761612
The table below shows BICYCLE THERAPEUTICS plc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$249.68M | -$164.72M | -$60.63M | -$86.11M | -$14.79M | -$17.79M |
| Capital expenditure | $2.35M | $1.24M | $2.93M | $18.99M | $2.03M | $1.20M |
| Investing cash flow | -$2.35M | -$1.24M | -$2.93M | -$18.99M | -$2.03M | -$1.20M |
| Dividends paid | - | - | - | - |
BICYCLE THERAPEUTICS plc reported operating cash flow of -$249.68M for fiscal year 2025. That is down 51.6% from -$164.72M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$1.42M (FY 2017) to -$249.68M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$131.00K | $519.75M | $250.03M | $6.69M | $320.73M | $62.84M |